Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study

NCT05246813 is registered in ClinicalTrials.gov with Imelda Hospital, Bonheiden as lead sponsor.

NCT NCT05246813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study
Lead sponsor
Imelda Hospital, Bonheiden
Phase
Observational
Overall status
Recruiting
Start date
February 11, 2022
Completion date
December 31, 2030
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, clonal hematopoiesis of indeterminate potential, hip fractures, osteoarthritis, hip, osteoporosis